EyePoint Pharmaceuticals, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
11.98
+0.48 (4.17%)
At close: Oct 24, 2025, 4:00 PM EDT
11.97
-0.01 (-0.08%)
After-hours: Oct 24, 2025, 7:05 PM EDT
EyePoint Pharmaceuticals Employees
EyePoint Pharmaceuticals had 165 employees as of December 31, 2024. The number of employees increased by 44 or 36.36% compared to the previous year.
Employees
165
Change (1Y)
44
Growth (1Y)
36.36%
Revenue / Employee
$314,533
Profits / Employee
-$1,062,915
Market Cap
957.53M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 165 | 44 | 36.36% |
| Dec 31, 2023 | 121 | -23 | -15.97% |
| Dec 31, 2022 | 144 | 21 | 17.07% |
| Dec 31, 2021 | 123 | 22 | 21.78% |
| Dec 31, 2020 | 101 | 17 | 20.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
EYPT News
- 10 days ago - EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 11 days ago - EyePoint Pharmaceuticals Raises Capital As It Advances Lead Product To Pivotal Study - Benzinga
- 11 days ago - EyePoint Announces Pricing of Public Offering - GlobeNewsWire
- 11 days ago - EyePoint Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 12 days ago - EyePoint Announces Pivotal Phase 3 Program Initiation for DURAVYU™ in Diabetic Macular Edema - GlobeNewsWire
- 7 weeks ago - EyePoint Pharmaceuticals, Inc. (EYPT) Presents At Citi's Biopharma Back To School Conference Transcript - Seeking Alpha
- 2 months ago - EyePoint Announces Participation at Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - EyePoint Pharmaceuticals, Inc. (EYPT) Q2 2025 Earnings Call Transcript - Seeking Alpha